Literature DB >> 11283083

Molecular characteristic-based epidemiology of hepatitis B, C, and E viruses and GB virus C/hepatitis G virus in Myanmar.

K Nakai1, K M Win, S S Oo, Y Arakawa, K Abe.   

Abstract

We carried out a molecular characteristic-based epidemiological survey of various hepatitis viruses, including hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis E virus (HEV), and GB virus C (GBV-C)/hepatitis G virus (HGV), in Myanmar. The study population of 403 subjects consisted of 213 healthy individuals residing in the city of Yangon, Myanmar, and the surrounding suburbs and 190 liver disease patients (155 virus-related liver disease patients and 35 nonviral disease patients). The infection rates of the viruses among the 213 healthy subjects were as follows: 8% for HBV (16 patients), 2% for HCV (4 patients), and 8% for GBV-C/HGV (17 patients). In contrast, for 155 patients with acute hepatitis, chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma, the infection rates were 30% for HBV (46 patients), 27% for HCV (41 patients), and 11% for GBV-C/HGV (17 patients). In the nonviral liver disease group of 35 patients with alcoholic liver disease, fatty liver, liver abscess, and biliary disease, the infection rates were 6% for HBV (2 patients), 20% for HCV (7 patients), and 26% for GBV-C/HGV (9 patients). The most common viral genotypes were type C of HBV (77%), type 3b of HCV (67%), and type 2 of GBV-C/HGV (67%). Moreover, testing for HEV among 371 subjects resulted in the detection of anti-HEV immunoglobulin G (IgG) in 117 patients (32%). The age prevalence of anti-HEV IgG was 3% for patients younger than 20 years and 30% or more for patients 20 years of age or older. Furthermore, a high prevalence of anti-HEV IgG (24%) was also found in swine living together with humans in Yangon. These results suggest that these hepatitis virus infections are widespread in Myanmar and have led to a high incidence of acute and chronic liver disease patients in the region.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283083      PMCID: PMC87966          DOI: 10.1128/JCM.39.4.1536-1539.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method.

Authors:  N Konomi; M Yamaguchi; H Naito; N Aiba; T Saito; Y Arakawa; K Abe
Journal:  Jpn J Infect Dis       Date:  2000-04       Impact factor: 1.362

2.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

Authors:  A Fujiyama; A Miyanohara; C Nozaki; T Yoneyama; N Ohtomo; K Matsubara
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

3.  Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers.

Authors:  H Naito; S Hayashi; K Abe
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

5.  Identification of a novel genotype of hepatitis G virus in Southeast Asia.

Authors:  H Naito; K M Win; K Abe
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

6.  Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using type-specific primers and geographical distribution of viral genotypes.

Authors:  H Naito; K Abe
Journal:  J Virol Methods       Date:  2001-01       Impact factor: 2.014

7.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

8.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

9.  Genetic and experimental evidence for cross-species infection by swine hepatitis E virus.

Authors:  X J Meng; P G Halbur; M S Shapiro; S Govindarajan; J D Bruna; I K Mushahwar; R H Purcell; S U Emerson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.

Authors:  J M Pawlotsky; L Bélec; G Grésenguet; L Deforges; M Bouvier; J Duval; D Dhumeaux
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

View more
  10 in total

1.  Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma).

Authors:  Kyaw Soe; Yoshitaka Hishikawa; Yoshitaka Fukuzawa; Ne Win; Khine San Yin; Khin Maung Win; Aye Aye Myint; Takehiko Koji
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

2.  Hepatitis C virus genotypes in Myanmar.

Authors:  Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Osamu Yokosuka; Hiroshi Shirasawa
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 3.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

4.  Bayesian coalescent analysis reveals a high rate of molecular evolution in GB virus C.

Authors:  Camila M Romano; Paolo M de A Zanotto; Edward C Holmes
Journal:  J Mol Evol       Date:  2008-03-05       Impact factor: 2.395

5.  Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.

Authors:  Rujipat Wasitthankasem; Sompong Vongpunsawad; Nipaporn Siripon; Chutima Suya; Phrutsada Chulothok; Kasemporn Chaiear; Pairaya Rujirojindakul; Sawan Kanjana; Apiradee Theamboonlers; Pisit Tangkijvanich; Yong Poovorawan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  Hepatitis B Virus Genotype C is Predominant in Myanmar.

Authors:  Nan Nwe Win; Shingo Nakamoto; Myint Myint Sein; Mitsuhiko Moriyama; Tatsuo Kanda; Hiroshi Shirasawa
Journal:  Diseases       Date:  2017-12-26

Review 7.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

8.  Sustained Virologic Response to a Dual Peginterferon alfa-2a and Ribavirin in Treating Chronic hepatitis C Infection: A Retrospective Cohort Study.

Authors:  Cho Naing; Than Sitt; Aye Td Aung; Kyan Aung
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 9.  Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells.

Authors:  Deepa Rana; Yogesh Chawla; Sunil K Arora
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

10.  Detection of HBV Genotype C in Hepatocellular Carcinoma Patients from North East India: a Brief Report

Authors:  Manash P Sarma; Minakshi Bhattacharjee; Premashis Kar; Subhash Medhi
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.